MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells

MDR1(多药耐药性 1)可以调节乳腺癌细胞中的 GCS(葡萄糖神经酰胺合酶)

阅读:8
作者:Xiaofang Zhang, Xiaojuan Wu, Juan Li, Yanlin Sun, Peng Gao, Cuijuan Zhang, Hui Zhang, Gengyin Zhou

Conclusions

Our results demonstrate that MDR1 could increase cellular apoptosis by regulating the expression of GCS in breast cancer cells.

Methods

A plasmid with multidrug resistence 1(mdr1) cDNA was transfected into the sensitive breast cancer cell line MCF-7, while an RNA interference (RNAi) vector targeted mdr1 was transfected into the MDR cell line MCF-7/ADM. Then RT-PCR, Western blot, MTT, and flow cytometry were used to assess the expression and function of mdr1 and GCS. Result: The data displayed that up-regulation of mdr1 could increase the expression of GCS, while the RNAi-expression plasmids could decrease that. Meantime, the changes of ceramide are opposed to that of GCS and are the same to the alteration of apoptosis rate. Conclusions: Our

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。